Cytokinetics, Incorporated (FRA:KK3A)
52.50
0.00 (0.00%)
Last updated: Jan 6, 2026, 8:00 AM CET
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of €6.57 billion as of January 9, 2026. Its market cap has increased by 18.26% in one year.
Market Cap
6.57B
Enterprise Value
6.90B
Revenue
74.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€52.50
Market Cap Chart
Since April 29, 2004, Cytokinetics's market cap has increased from 31.10M to 6.57B, an increase of 21,027.44%. That is a compound annual growth rate of 27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 6.57B | -0.70% |
| Dec 31, 2025 | 6.62B | 23.40% |
| Dec 31, 2024 | 5.36B | -27.60% |
| Dec 29, 2023 | 7.41B | 82.55% |
| Dec 30, 2022 | 4.06B | 20.68% |
| Dec 31, 2021 | 3.36B | 179.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |